TWD 18.0
(-14.29%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 93.33 Million TWD | -22.1% |
2022 | 119.81 Million TWD | 26.88% |
2021 | 94.42 Million TWD | 24.58% |
2020 | 75.79 Million TWD | -18.9% |
2019 | 93.45 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 16.06 Thousand TWD | -30.06% |
2024 Q2 | 16.06 Thousand TWD | 0.0% |
2023 FY | 93.33 Million TWD | -22.1% |
2023 Q4 | 22.96 Thousand TWD | 0.0% |
2023 Q3 | 22.96 Thousand TWD | -2.57% |
2023 Q2 | 23.57 Thousand TWD | 0.0% |
2023 Q1 | 23.57 Thousand TWD | -25.12% |
2022 Q3 | 31.48 Thousand TWD | 0.0% |
2022 FY | 119.81 Million TWD | 26.88% |
2022 Q4 | 31.48 Thousand TWD | 0.0% |
2021 FY | 94.42 Million TWD | 24.58% |
2020 FY | 75.79 Million TWD | -18.9% |
2019 FY | 93.45 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -28269.605% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 26.893% |
Level Biotechnology Inc. | 151.99 Million TWD | 38.592% |
Sagittarius Life Science Corp | 135.85 Million TWD | 31.296% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -23.039% |
TaiMed Biologics Inc. | 225.23 Million TWD | 58.56% |
GlycoNex Incorporation | 995 Thousand TWD | -9280.503% |
VBI | 32.55 Million TWD | -186.703% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 63.664% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 51.935% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -102.803% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 22.162% |
Visgeneer Inc. | 67.48 Million TWD | -38.312% |
Mycenax Biotech Inc. | -375.19 Million TWD | 124.877% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 81.702% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -46.059% |
Neith Corporation | 66.87 Million TWD | -39.572% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 93.537% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -217.989% |
Enimmune corporation | 220.1 Million TWD | 57.594% |
TaiRx, Inc. | 217.13 Million TWD | 57.015% |
CHO Pharma, Inc. | 268.99 Million TWD | 65.302% |
EirGenix Inc. | 236.74 Million TWD | 60.575% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 10.556% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 73.901% |
Lin BioScience, Inc. | 1.09 Billion TWD | 91.49% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 64.932% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -88.668% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -8518.283% |
Lukas Biomedical Inc. | 177.45 Million TWD | 47.402% |
RBC Bioscience Corporation | 58.35 Million TWD | -59.942% |
BiOptic Inc. | 108.69 Million TWD | 14.128% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -103606.667% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -34.587% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -3469.254% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 85.505% |
NaviFUS Corp. | 11.82 Million TWD | -689.177% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 51.064% |
Sinew Pharma Inc. | 186.25 Million TWD | 49.888% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -26.091% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 57.651% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -125.009% |
AP Biosciences Inc | 32.25 Million TWD | -189.387% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 94.956% |
3D Global Biotech Inc. | 5.27 Million TWD | -1669.738% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 70.587% |
Intech Biopharm Corporation | -163.99 Million TWD | 156.914% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 91.734% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -125.004% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 44.953% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 36.516% |
TCI GENE Inc. | 174.61 Million TWD | 46.548% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -518433.333% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 68.985% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 67.921% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -11.187% |
PharmaEngine, Inc. | 441.78 Million TWD | 78.873% |
Savior Lifetec Corporation | 223.36 Million TWD | 58.214% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 63.932% |
OBI Pharma, Inc. | 2.01 Billion TWD | 95.371% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 32.789% |
Acepodia, Inc. | 452.56 Million TWD | 79.376% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 82.745% |